Timothy J. Scannell, Director at NovoCure Ltd (NVCR), sold 2,945 shares at $15.77 ($46K) on 2026-06-02, disclosed to the SEC on 2026-06-03.
Seasonal sale ($46k) by Director — this insider has traded NVCR in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| PODD | SELL | 2024-06-11 | $1.3M | — | Filing → |
| NVCR | SELL | 2024-06-06 | $23K | — | Filing → |
| PODD | SELL | 2024-05-29 | $597K | — | Filing → |